Cardiology Trials
By Cardiology Trials
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Cardiology Trials
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 15
Reviews: 0
Episodes: 143
Description
An exploration of pivotal clinical trials in cardiovascular medicine that have significantly influenced the field. This podcast aligns with our publications on the Cardiology Trial's Substack.
cardiologytrials.substack.com
cardiologytrials.substack.com
| Episode | Date |
|---|---|
|
Summary and discussion of AFFIRM and RACE
|
Jun 03, 2026 |
|
Special episode (ACC 2026: CHAMPION-AF, HI-PEITHO)
|
Apr 06, 2026 |
|
Summary and discussion of VICTORIA and VICTOR
|
Mar 16, 2026 |
|
Summary and discussion of DAPA-HF and EMPEROR-Reduced
|
Feb 10, 2026 |
|
Special episode (AHA 2025: OCEAN, ADAPT AF-DES)
|
Dec 29, 2025 |
|
Special episode (AHA 2025: VESALIUS-CV, DECAF)
|
Dec 08, 2025 |
|
Summary and discussion of PARADIGM-HF and PIONEER-HF
|
Nov 20, 2025 |
|
Special episode (ESC 2025: AQUATIC, VICTOR)
|
Sep 25, 2025 |
|
Special episode (ESC 2025: REBOOT-CNIC, BETAMI-DANBLOCK, DIGIT-HF)
|
Sep 09, 2025 |
|
Summary and discussion of BEST and SENIORS
|
Aug 15, 2025 |
|
Review of the A-HeFT trial
|
Jul 01, 2025 |
|
Review of the CHARM-Alternative trial
|
Jun 24, 2025 |
|
Summary and discussion of Carvedilol Prospective Randomized Cumulative Survival Study, Val-HeFT, CHARM-Added and CIBIS-II
|
Jun 19, 2025 |
|
Review of the CIBIS-II Trial
|
Jun 17, 2025 |
|
Review of the CHARM-Added trial
|
Jun 11, 2025 |
|
Review of the Val-HeFT trial
|
Jun 06, 2025 |
|
Review of the Carvedilol Prospective Randomized Cumulative Survival Study
|
Jun 04, 2025 |
|
Summary and discussion of U.S. Carvedilol Heart Failure, DIG, RALES, MERIT-HF, and ATLAS
|
May 30, 2025 |
|
Review of the ATLAS trial
|
May 27, 2025 |
|
Review of the MERIT-HF trial
|
May 22, 2025 |
|
Review of the RALES trial
|
May 20, 2025 |
|
Review of the DIG trial
|
May 16, 2025 |
|
Review of the U.S. Carvedilol Heart Failure Study
|
May 14, 2025 |
|
Summary and discussion of V-HEFT II and SOLVD
|
May 09, 2025 |
|
Review of the SOLVD trials
|
May 08, 2025 |
|
Review of the V-HEFT II trial
|
May 06, 2025 |
|
Summary and discussion of V-HEFT I and CONSENSUS
|
May 02, 2025 |
|
Review of the CONSENSUS trial
|
May 01, 2025 |
|
Review of the V-HEFT I Trial
|
Apr 29, 2025 |
|
Review of the CULPRIT-SHOCK Trial
|
Apr 17, 2025 |
|
Summary and discussion of MOSCA-FRAIL and SENIOR-RITA
|
Apr 15, 2025 |
|
Review of the SENIOR-RITA trial
|
Apr 10, 2025 |
|
Review of the MOSCA-FRAIL trial
|
Apr 08, 2025 |
|
Summary and discussion of TACTICS-TIMI 18, RITA 3 and ICTUS
|
Apr 03, 2025 |
|
Review of the ICTUS trial
|
Apr 01, 2025 |
|
Review of the RITA 3 trial
|
Mar 27, 2025 |
|
Review of the TACTICS-TIMI 18 trial
|
Mar 13, 2025 |
|
Summary and discussion of PRAMI, COMPLETE and FULL REVASC
|
Mar 11, 2025 |
|
Review of the FULL REVASC trial
|
Mar 06, 2025 |
|
Review of the COMPLETE trial
|
Mar 05, 2025 |
|
Review of the PRAMI Trial
|
Feb 27, 2025 |
|
Summary and discussion of TAPAS and TASTE
|
Feb 25, 2025 |
|
Summary and discussion of trials of fibrinolysis vs invasive strategy in STEMI
|
Feb 20, 2025 |
|
Review of the TASTE trial
|
Feb 18, 2025 |
|
Summary and discussion of OAT
|
Feb 13, 2025 |
|
Review of the TAPAS trial
|
Feb 11, 2025 |
|
Review of the STREAM trial
|
Feb 09, 2025 |
|
Summary and discussion of FAME and RIVAL
|
Jan 30, 2025 |
|
Review of the OAT Trial
|
Jan 29, 2025 |
|
Review of the DANAMI-2 trial
|
Jan 23, 2025 |
|
Review of the Primary Angioplasty in Myocardial Infarction Study Group trial
|
Jan 21, 2025 |
|
Review of the RIVAL trial
|
Jan 16, 2025 |
|
Review of the FAME trial
|
Jan 15, 2025 |
|
Summary and discussion of NORSTENT
|
Jan 09, 2025 |
|
Review of the NORSTENT trial
|
Jan 02, 2025 |
|
Our discussion of "Revisiting the PLATO trial"
|
Dec 23, 2024 |
|
Revisiting the PLATO trial
|
Dec 23, 2024 |
|
Summary and discussion of RAVEL, TAXUS-IV and SPIRIT IV
|
Dec 19, 2024 |
|
Review of the SPIRIT IV Trial
|
Dec 16, 2024 |
|
Review of the TAXUS-IV trial
|
Dec 12, 2024 |
|
Review of the RAVEL trial
|
Dec 10, 2024 |
|
Summary and discussion of FAME 3, BARI 2D and PREVENT
|
Dec 06, 2024 |
|
Review of the PREVENT trial
|
Dec 04, 2024 |
|
Summary and discussion of trials of PCI vs CABG
|
Dec 02, 2024 |
|
Review of the BARI 2D trial
|
Nov 22, 2024 |
|
Review of the FAME 3 trial
|
Nov 07, 2024 |
|
Review of the EXCEL trial
|
Nov 01, 2024 |
|
Review of the NOBLE Trial
|
Oct 31, 2024 |
|
Review of the FREEDOM trial
|
Oct 25, 2024 |
|
Review of the SYNTAX trial
|
Oct 22, 2024 |
|
Review of the ORBITA-2 trial
|
Oct 11, 2024 |
|
Summary and discussion of ISCHEMIA, ISCHEMIA-CKD, ORBITA and REVIVED-BCIS2
|
Oct 04, 2024 |
|
Review of the REVIVED-BCIS2 trial
|
Oct 01, 2024 |
|
Review of the ORBITA trial
|
Sep 26, 2024 |
|
Review of the ISCHEMIA and ISCHEMIA-CKD trials
|
Sep 23, 2024 |
|
Summary and discussion of RITA-2, atorvastatin vs angioplasty, COURAGE and FAME 2
|
Sep 17, 2024 |
|
Review of the FAME 2 Trial
|
Sep 12, 2024 |
|
Review of the COURAGE Trial
|
Sep 10, 2024 |
|
Review of the Atorvastatin versus Revascularization Treatment Investigators Trial
|
Sep 05, 2024 |
|
Review of the RITA-2 trial
|
Aug 27, 2024 |
|
Summary and discussion of STICH and ACME
|
Aug 22, 2024 |
|
Review of the ACME trial
|
Aug 20, 2024 |
|
Review of the STICH trial
|
Aug 15, 2024 |
|
Summary and discussion of trials of coronary artery bypass surgery in stable angina
|
Aug 13, 2024 |
|
Review of the Coronary Artery Bypass Graft Surgery Trialists Collaboration
|
Aug 09, 2024 |
|
Review of the Coronary Artery Surgery Study (CASS)
|
Aug 06, 2024 |
|
Review of the European Coronary Surgery Study
|
Aug 01, 2024 |
|
Review of the Veterans Administration Cooperative Study
|
Jul 30, 2024 |
|
A review of medical management after acute coronary syndrome
|
Jul 12, 2024 |
|
Summary and discussion of REDUCE-AMI
|
Jul 05, 2024 |
|
Review of the REDUCE-AMI trial
|
Jul 02, 2024 |
|
Summary and discussion of PARADISE-MI and EMPACT-MI
|
Jun 28, 2024 |
|
Review of the EMPACT-MI Trial
|
Jun 27, 2024 |
|
Review of the PARADISE-MI Trial
|
Jun 25, 2024 |
|
Summary and discussion of IMPROVE-IT, CANTOS, CIRT and COLCOT
|
Jun 20, 2024 |
|
Review of the COLCOT trial
|
Jun 13, 2024 |
|
Review of the CIRT trial
|
Jun 10, 2024 |
|
Review of the CANTOS Trial
|
Jun 03, 2024 |
|
Review of the IMPROVE-IT trial
|
May 28, 2024 |
|
Summary and discussion of ACCOAST and ISAR-REACT 5
|
May 23, 2024 |
|
Review of the ISAR-REACT 5 Trial
|
May 16, 2024 |
|
Review of the ACCOAST trial
|
May 14, 2024 |
|
Summary and discussion of TACT and ATLANTIC
|
May 09, 2024 |
|
Review of the ATLANTIC trial
|
May 02, 2024 |
|
Summary and discussion of NICE-SUGAR, TRITON-TIMI 38, TRILOGY ACS, PLATO and ATLAS ACS 2-TIMI 51
|
Apr 29, 2024 |
|
Review of the TACT Trial
|
Apr 25, 2024 |
|
Review of the ATLAS ACS 2-TIMI 51 trial
|
Apr 23, 2024 |
|
Review of the CURRENT-OASIS 7 trial
|
Apr 18, 2024 |
|
Review of the TRILOGY ACS trial
|
Apr 16, 2024 |
|
Review of the PLATO Trial
|
Apr 04, 2024 |
|
Review of the TRITON-TIMI 38 Trial
|
Apr 02, 2024 |
|
Review of the HORIZONS-AMI trial
|
Mar 28, 2024 |
|
Review of the OASIS-6 trial
|
Mar 26, 2024 |
|
Review of the OASIS-5 trial
|
Mar 12, 2024 |
|
Summary and discussion of CURE and DIGAMI 2
|
Mar 11, 2024 |
|
Review of DIGAMI 2
|
Mar 07, 2024 |
|
Review of the CURE Trial
|
Mar 05, 2024 |
|
Summary and discussion of MIRACL and PROVE IT-TIMI 22
|
Mar 04, 2024 |
|
Review of the PROVE IT-TIMI 22 Trial
|
Feb 29, 2024 |
|
Review of the MIRACL Trial
|
Feb 27, 2024 |
|
Summary and discussion of DIGAMI and FRISC
|
Feb 26, 2024 |
|
Review of the FRISC trial
|
Feb 22, 2024 |
|
Review of the DIGAMI trial
|
Feb 20, 2024 |
|
Summary and discussion of TRACE and EPHESUS
|
Feb 19, 2024 |
|
Review of the EPHESUS Trial
|
Feb 15, 2024 |
|
Review of the TRACE Study
|
Feb 13, 2024 |
|
Summary and discussion of CAPRICORN and COMMIT
|
Feb 12, 2024 |
|
Review of the COMMIT Trial
|
Feb 08, 2024 |
|
Review of the CAPRICORN Trial
|
Feb 06, 2024 |
|
Summary and discussion of SAVE and AIRE
|
Feb 05, 2024 |
|
Review of Acute Infarction Ramipril Efficacy (AIRE) Trial
|
Feb 01, 2024 |
|
Review of Survival and Ventricular Enlargement (SAVE) Trial
|
Jan 30, 2024 |
|
Summary and discussion of GISSI-3 and ISIS-4
|
Jan 29, 2024 |
|
Review of the ISIS-4 Trial
|
Jan 25, 2024 |
|
Review of the GISSI-3 Trial
|
Jan 23, 2024 |
|
Summary and discussion of CAST and ISIS-3
|
Jan 22, 2024 |
|
Review of the ISIS-3 Trial
|
Jan 18, 2024 |
|
Review of the Cardiac Arrhythmia Suppression Trial (CAST)
|
Jan 16, 2024 |
|
Summary and discussion of GISSI-1, 2 and ISIS-2
|
Jan 15, 2024 |
|
Review of the GISSI-2 Trial
|
Jan 12, 2024 |
|
Review of the ISIS-2 Trial
|
Jan 10, 2024 |
|
Review of the GISSI-1 Trial
|
Jan 08, 2024 |
|
BHAT and ISIS-I trials
|
Jan 05, 2024 |